Altered neural cholinergic receptor systems in cocaine-addicted subjects

Neuropsychopharmacology

Volumn 35, Issue 7, 2010, Pages 1485-1499

  Adinoff, Bryon ^a,b   Devous, Michael D ^c   Williams, Mark J ^a   Best, Susan E ^a,b   Harris, Thomas S ^c   Minhajuddin, Abu ^a   Zielinski, Tanya ^a   Cullum, Munro ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acetylcholine; Addiction and substance abuse; Biological psychiatry; Clinical or preclinical; Cocaine addiction; Imaging

Indexed keywords

CHOLINERGIC RECEPTOR; COCAINE; MUSCARINIC AGENT; NICOTINE; NICOTINIC AGENT; ONDANSETRON; PHYSOSTIGMINE; SCOPOLAMINE; SODIUM CHLORIDE; TECHNETIUM 99M;

ABSTINENCE; ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN BLOOD FLOW; CINGULATE GYRUS; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG HALF LIFE; FEMALE; HIPPOCAMPUS; HUMAN; INSULA; LEARNING; LIMBIC CORTEX; LOADING DRUG DOSE; MALE; MEMORY; NEUROIMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WITHDRAWAL SYNDROME;

ADULT; BLOOD PRESSURE; BRAIN MAPPING; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE INHIBITORS; COCAINE-RELATED DISORDERS; FEMALE; HEART RATE; HUMANS; LIMBIC SYSTEM; MALE; PHYSOSTIGMINE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, CHOLINERGIC; SCOPOLAMINE; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77952426519     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.18     Document Type: Article

References (98)

1. Adinoff B, Rilling LM, Williams MJ, Schreffler ER, Schepis TY, Rosvall T et al (2007). Impulsivity, neural deficits, and the addictions: the 'Oops' factor in relapse. J Addict Dis 26(Suppl 1): 25-39.
2. Adinoff B, Williams MJ, Best SE, Harris TS, Chandler P, Devous Sr MD (2006). Sex differences in medial and lateral orbitofrontal cortex hypoperfusion in cocaine-dependent men and women. Gend Med 3: 206-222.
3. Ahveninen J, Tiitinen H, Hirvonen J, Pekkonen E, Huttunen J, Kaakkola S et al (1999). Scopolamine augments transient auditory 40-hz magnetic response in humans. Neurosci Lett 277: 115-118.
4. Bartzokis G, Beckson M, Lu PH, Edwards N, Bridge P, Mintz J (2002). Brain maturation may be arrested in chronic cocaine addicts. Biol Psychiatry 51: 605-611.
5. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57: 289-300.
6. Berlanga ML, Olsen CM, Chen V, Ikegami A, Herring BE, Duvauchelle CL et al (2003). Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. Neuroscience 120: 1149-1156. (Pubitemid 36966664)
7. Berlanga ML, Simpson TK, Alcantara AA (2005). Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release. J Comp Neurol 492: 34-49.
8. Blin J, Ivanoiu A, Coppens A, De Volder A, Labar D, Michel C et al (1997). Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patients. Neuroimage 6: 335-343.
9. Blin J, Ray CA, Piercey MF, Bartko JJ, Mouradian MM, Chase TN (1994a). Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography. Brain Res 635: 196-202.
10. Blin J, Ray CA, Piercey MF, Bartko JJ, Mouradian MM, Chase TN (1994b). Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography. Brain Res 635: 196-202.
11. Bohnen NI, Frey KA (2007). Imaging of cholinergic and mono-aminergic neurochemical changes in neurodegenerative disorders. Mol Imaging Biol 9: 243-257.
12. Bonson KR, Grant SJ, Contoreggi CS, Links JM, Metcalfe J, Weyl HL et al (2002). Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 26: 376-386.
13. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D et al (2006). Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 63: 907-915.
14. Carson RE, Kiesewetter DO, Jagoda E, Der MG, Herscovitch P, Eckelman WC (1998). Muscarinic cholinergic receptor measurements with [18F]FP-TZTP: control and competition studies. J Cereb Blood Flow Metab 18: 1130-1142.
15. Chen KC, Baxter MG, Rodefer JS (2004). Central blockade of muscarinic cholinergic receptors disrupts affective and atten-tional set-shifting. Eur J Neurosci 20: 1081-1088.
16. Clarke PB, Pert A (1985). Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348: 355-358. (Pubitemid 16231720)
17. Consolo S, Caltavuturo C, Colli E, Recchia M, Di Chiara G (1999). Different sensitivity of in vivo acetylcholine transmission to D1 receptor stimulation in shell and core of nucleus accumbens. Neuroscience 89: 1209-1217.
18. Cosgrove KP, Mitsis EM, Bois F, Frohlich E, Tamagnan GD, Krantzler E et al (2007). 123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase. J Nucl Med 48: 1633-1640.
19. Craig AD (2003). Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol 13: 500-505.
20. Crespo JA, Sturm K, Saria A, Zernig G (2006). Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement. J Neurosci 26: 6004-6010.
21. Crombag HS, Bossert JM, Koya E, Shaham Y (2008). Review. Context-induced relapse to drug seeking: a review. Philos Trans R Soc Lond B Biol Sci 363: 3233-3243.
22. de la Garza R, Johanson CE (1982). Effects of haloperidol and physostigmine on self-administration of local anesthetics. Pharmacol Biochem Behav 17: 1295-1299.
23. De La Garza R, Shoptaw S, Newton TF (2008). Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Int J Neuropsychopharmacol 11: 729-741.
24. Derogatis LR, Melisaratos N (1983). The Brief Symptom Inventory: an introductory report. Psychol Med 13: 595-605.
25. Devous Sr MD (2002). SPECT functional brain imaging. In: Mazziotta JC, Toga AW (eds). BrainMapping: The Methods. Second edn. Academic Press: San Diego. pp 513-533.
26. Dick DM, Aliev F, Wang JC, Grucza RA, Schuckit M, Kuperman S et al (2008). Using dimensional models of externalizing psychopathology to aid in gene identification. Arch Gen Psychiatry 65: 310-318.
27. Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA et al (2000a). Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse 38: 313-321.
28. Domino EF, Minoshima S, Guthrie SK, Ohl L, Ni L, Koeppe RA et al (2000b). Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience 101: 277-282.
29. Easwaramoorthy B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J (2007). Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: a measure of acetylcholine competition. Synapse 61: 29-36.
30. Fink-Jensen A, Fedorova I, Wortwein G, Woldbye DP, Rasmussen T, Thomsen M et al (2003). Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci Res 74: 91-96.
31. First MH, Spitzer RL, Miriam G, Williams JBW (2002). Structured Clinical Interview for DSM-IV Axis I DisordersFPatient Edition (SCID-I/P). Biometrics Research Department, New York State Psychiatric Institute: NY.
32. Flynn DD, Vaishnav AA, Mash DC (1992a). Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Mol Pharmacol 41: 736-742.
33. Flynn DD, Vaishnav AA, Mash DC (1992b). Interactions of cocaine with primary and secondary recognition siteson muscarinic receptors. Mol Pharmacol 41: 736-742.
34. Franklin TR, Acton PD, Maldjian JA, Gray JD, Croft JR, Dackis CA et al (2002). Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry 51: 134-142.
35. Furey ML, Pietrini P, Alexander GE, Mentis MJ, Szczepanik J, Shetty U et al (2000). Time course of pharmacodynamic and pharmacokinetic effects of physostigmine assessed by functional brain imaging in humans. Pharmacol Biochem Behav 66: 475-481.
36. Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ et al (2000). Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 157: 1789-1798.
37. Geaney DP, Soper N, Shepstone BJ, Cowen PJ (1990). Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease. Lancet 335: 1484-1487.
38. Grant S, London ED, Newlin DB, Villemagne VL, Liu X, Contoreggi C et al (1996). Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 93: 12040-12045.
39. Gustafson L, Edvinsson L, Dahlgren N, Hagberg B, Risberg J, Rosen I et al (1987). Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. Psychophar-macology (Berl) 93: 31-35.
40. Hasselmo ME (1995). Neuromodulation and cortical function: modeling the physiological basis of behavior. Behav Brain Res 67: 1-27.
41. Horner B, Scheibe K, Stine S (1996). Cocaine abuse and attention-deficit hyperactivity disorder: implications of adult symptomatology. Psychol Addict Behav 10: 55-60.
42. Imperato A, Obinu MC, Gessa GL (1993a). Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur J Pharmacol 238: 377-381.
43. Imperato A, Obinu MC, Gessa GL (1993b). Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus. Brain Res 618: 341-345. (Pubitemid 23207979)
44. Imperato A, Obinu MC, Mascia MS, Casu MA, Zocchi A, Cabib S et al (1996). Strain-dependent effects of dopamine agonists on acetylcholine release in the hippocampus: an in vivo study in mice. Neuroscience 70: 653-660.
45. Jovanovski D, Erb S, Zakzanis KK (2005). Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Exp Neuropsychol 27: 189-204.
46. Kalman D, Morissette SB, George TP (2005). Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14: 106-123.
47. Karpen JW, Hess GP (1986). Cocaine, phencyclidine, and procaine inhibition of the acetylcholine receptor: characterization of the binding site by stopped-flow measurements of receptor-controlled ion flux in membrane vesicles. Biochemistry (Mosc) 25: 1777-1785.
48. Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL, Muhammad F et al (2001). Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 58: 334-341.
49. Koeppe RA, Frey KA, Snyder SE, Kilbourn MR, Kuhl DE (1997). Evaluation of two distinct kinetic analyses for use with [C-11]PMP: an irreversible tracer for mapping AChE activity. J Cereb Blood Flow Metab 17: S329.
50. Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R et al (2006). Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology 31: 644-650.
51. Kotani S, Yamauchi T, Teramoto T, Ogura H (2008). Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chem Biol Interact 175: 227-230.
52. Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL et al (1999). In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 52: 691-699.
53. Li CS, Kosten TR, Sinha R (2005). Sex differences in brain activation during stress imagery in abstinent cocaine users: a functional magnetic resonance imaging study. Biol Psychiatry 57: 487-494.
54. Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP (2002). Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry 51: 890-895.
55. Lipton JW, Olsen RW, Ellison GD (1995). Length of continuous cocaine exposure determines the persistence of muscarinic and benzodiazepine receptor alterations. Brain Res 676: 378-385.
56. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW et al (1998). Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry 155: 124-126.
57. Macedo DS, Correia EE, Vasconcelos SM, Aguiar LM, Viana GS, Sousa FC (2004). Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors. Cell Mol Neurobiol 24: 129-136.
58. Mansvelder HD, De Rover M, McGehee DS, Brussaard AB (2003). Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. Eur J Pharmacol 480: 117-123.
59. Mark GP, Hajnal A, Kinney AE, Keys AS (1999). Self-administration of cocaine increases the release of acetylcholine to a greater extent than response-independent cocaine in the nucleus accumbens of rats. Psychopharmacology (Berl) 143: 47-53.
60. Matochik JA, London ED, Eldreth DA, Cadet JL, Bolla KI (2003). Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 19: 1095-1102.
61. Meador KJ, Loring DW, Hendrix N, Nichols ME, Oberzan R, Moore EE (1995a). Synergistic anticholinergic and antiseroto-nergic effects in humans. J Clin Exp Neuropsychol 17: 611-621.
62. Meador KJ, Loring DW, Hendrix N, Nichols ME, Oberzan R, Moore EE (1995b). Synergistic anticholingergic and antiseroto-nergic effects in humans. J Clin Exp Neuropsychol 17: 611-621.
63. Mesulam MM (1996). The systems-level organization of choliner-gic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Prog Brain Res 109: 285-297.
64. Meyers RA, Zavala AR, Speer CM, Neisewander JL (2006). Dorsal hippocampus inhibition disrupts acquisition and expression, but not consolidation, of cocaine conditioned place preference. Behav Neurosci 120: 401-412.
65. Namba H, Iyo M, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T et al (1999). Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age. Eur J Nucl Med 26: 135-143.
66. Naqvi NH, Rudrauf D, Damasio H, Bechara A (2007). Damage to the insula disrupts addiction to cigarette smoking. Science 315: 531-534.
67. Noonan MA, Choi KH, Self DW, Eisch AJ (2008). Withdrawal from cocaine self-administration normalizes deficits in proliferation and enhances maturity of adult-generated hippocampal neurons. J Neurosci 28: 2516-2526.
68. Paulus MP, Tapert SF, Schuckit MA (2005). Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry 62: 761-768.
69. Ragozzino ME, Choi D (2004). Dynamic changes in acetylcholine output in the medial striatum during place reversal learning. Learn Mem 11: 70-77.
70. Reiman EM, Lane RD, Ahern GL, Schwartz GE, Davidson RJ, Friston KJ et al (1997). Neuroanatomical correlates of externally and internally generated human emotion. Am J Psychiatry 154: 918-928.
71. Risinger RC, Salmeron BJ, Ross TJ, Amen SL, Sanfilipo M, Hoffmann RG et al (2005). Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuro-image 26: 1097-1108.
72. Robbins TW (2002). The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163: 362-380.
73. Robinson SE, Hambrecht KL (1988). The effect of cocaine on hippocampal cholinergic and noradrenergic metabolism. Brain Res 457: 383-385.
74. Rose JE, Behm FM, Westman EC, Mathew RJ, London ED, Hawk TC et al (2003). PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry 160: 323-333.
75. Sarter M, Bruno JP, Givens B (2003). Attentional functions of cortical cholinergic inputs: what does it mean for learning and memory? Neurobiol Learn Mem 80: 245-256.
76. Sasaki M, Tohyama K, Matsunaga S, Nakamura M, Tomizawa N, Inoue T et al (2004). MRI identification of dorsal hippocampus homologue in human brain. Neuroreport 15: 2173-2176.
77. Schroeder JP, Packard MG (2004). Facilitation of memory for extinction of drug-induced conditioned reward: role of amygdala and acetylcholine. Learn Mem 11: 641-647.
78. See RE, McLaughlin J, Fuchs RA (2003). Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats. Neuroscience 117: 477-483.
79. Seeger T, Fedorova I, Zheng F, Miyakawa T, Koustova E, Gomeza J et al (2004). M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity. J Neurosci 24: 10117-10127.
80. Sharkey J, Ritz MC, Schenden JA, Hanson RC, Kuhar MJ (1988a). Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246: 1048-1052.
81. Sharkey J, Ritz MC, Schenden JA, Hanson RC, Kuhar MJ (1988b). Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246: 1048-1052.
82. Smith JE, Co C, Yin X, Sizemore GM, Liguori A, Johnson III WE et al (2004a). Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci Biobehav Rev 27: 841-850.
83. Smith JE, Vaughn TC, Co C (2004b). Acetylcholine turnover rates in rat brain regions during cocaine self-administration. J Neurochem 88: 502-512.
84. Smith YR, Minoshima S, Kuhl DE, Zubieta JK (2001). Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J Clin Endocrinol Metab 86: 679-684.
85. Sobell MB, Sobell LC (1978). Behavioral Treatment of Alcohol Problems. Plenum Press: NewYork.
86. Sousa FC, Gomes PB, Macedo DS, Marinho MM, Viana GS (1999). Early withdrawal from repeated cocaine administration upregu-lates muscarinic and dopaminergic D2-like receptors in rat neostriatum. Pharmacol Biochem Behav 62: 15-20.
87. Thomsen M, Woldbye DP, Wortwein G, Fink-Jensen A, Wess J, Caine SB (2005). Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. J Neurosci 25: 8141-8149.
88. Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI et al (1990). Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. Arch Gen Psychiatry 47: 861-868.
89. Weiner DM, Levey AI, Brann MR (1990). Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87: 7050-7054.
90. Williams MJ, Adinoff B (2008). The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 33: 1779-1797.
91. Wilson MC, Schuster CR (1973). Cholinergic influence on intravenous cocaine self-administration by rhesus monkeys. Pharmacol Biochem Behav 1: 643-649.
92. Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Montgomery MA, Goldsmith RJ et al (2005). A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100(Suppl 1): 68-77.
93. Yamaguchi M, Suzuki T, Seki T, Namba T, Juan R, Arai H et al (2004). Repetitive cocaine administration decreases neurogenesis in adult rat hippocampus. Ann NY Acad Sci 1025: 351-362.
94. Yeomans J, Forster G, Blaha C (2001). M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci 68: 2449-2456.
95. Zeigler S, Lipton J, Toga A, Ellison G (1991). Continuous cocaine administration produces persisting changes in brain neuro-chemistry and behavior. Brain Res 552: 27-35.
96. Zhang W, Yamada M, Gomeza J, Basile AS, Wess J (2002). Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. J Neurosci 22: 6347-6352.
97. Zhou FM, Wilson C, Dani JA (2003). Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. Neuroscientist 9: 23-36.
98. Zubieta JK, Heitzeg MM, Xu Y, Koeppe RA, Ni L, Guthrie S et al (2005). Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. Am J Psychiatry 162: 567-577.